Tetrahydroisoquinolines as MCH-R1 antagonists

Bioorg Med Chem Lett. 2006 Sep 15;16(18):4917-21. doi: 10.1016/j.bmcl.2006.06.055. Epub 2006 Jul 7.

Abstract

A series of potent and selective inhibitors of h-MCH-R1 has been developed based on the piperidine glycineamide compounds I and II. These structurally more rigid tetrahydroisoquinolines (III and IV) showed better pharmacokinetics. The highly potent compounds 12d and 12g displayed excellent rat pk.

MeSH terms

  • Animals
  • Benzimidazoles / chemistry
  • Humans
  • Molecular Structure
  • Rats
  • Receptors, Somatostatin / antagonists & inhibitors*
  • Receptors, Somatostatin / metabolism
  • Structure-Activity Relationship
  • Tetrahydroisoquinolines / chemical synthesis*
  • Tetrahydroisoquinolines / chemistry
  • Tetrahydroisoquinolines / pharmacokinetics
  • Tetrahydroisoquinolines / pharmacology*

Substances

  • Benzimidazoles
  • MCHR1 protein, human
  • MCHR1 protein, rat
  • Receptors, Somatostatin
  • Tetrahydroisoquinolines
  • benzimidazole